2004
Favorable effect of γ‐radiation for in‐stent restenosis: Effect of diabetes on angiographic and clinical outcomes
Iakovou I, Mehran R, Dangas G, Lansky AJ, Stone GW, Mintz GS, Aymong E, Ashby DT, Pichard AD, Satler LF, Kent K, Leon MB, Waksman R. Favorable effect of γ‐radiation for in‐stent restenosis: Effect of diabetes on angiographic and clinical outcomes. Catheterization And Cardiovascular Interventions 2004, 62: 303-307. PMID: 15224295, DOI: 10.1002/ccd.20070.Peer-Reviewed Original ResearchConceptsTarget lesion revascularizationDiabetes mellitusStent restenosisMajor adverse cardiac event ratesAdverse cardiac event ratesIn-Stent Restenosis TrialLower target lesion revascularizationMajor adverse cardiac eventsNon-DM patientsAdverse cardiac eventsCardiac event rateTreatment of ISREffect of diabetesSimilar procedural successGamma radiation therapyLesion revascularizationHospital outcomesRestenosis TrialVessel revascularizationCardiac eventsProcedural successClinical outcomesWashington RadiationVascular brachytherapyPatients
2001
Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries
Baim D, Cutlip D, O’Shaughnessy C, Hermiller J, Kereiakes D, Giambartolomei A, Katz S, Lansky A, Fitzpatrick M, Popma J, Ho K, Leon M, Kuntz R, Investigators N. Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. The American Journal Of Cardiology 2001, 87: 152-156. PMID: 11152830, DOI: 10.1016/s0002-9149(00)01307-2.Peer-Reviewed Original ResearchConceptsPrimary end pointTarget vessel failureNIR stentPS stentBetter acute angiographic resultsTarget vessel failure rateMajor adverse cardiac eventsEnd pointSingle coronary lesionsAdverse cardiac eventsNative coronary arteriesNorth American trialsSuccessful stent deliveryAcute angiographic resultsPalmaz-Schatz stentsPrespecified cohortCardiac eventsAngiographic restudyAngiographic resultsCoronary lesionsPS patientsDiameter stenosisCoronary arteryVessel failureStent placementFinal results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries
Baim D, Cutlip D, Midei M, Linnemeier T, Schreiber T, Cox D, Kereiakes D, Popma J, Robertson L, Prince R, Lansky A, Ho K, Kuntz R, Investigators A. Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. The American Journal Of Cardiology 2001, 87: 157-162. PMID: 11152831, DOI: 10.1016/s0002-9149(00)01308-4.Peer-Reviewed Original ResearchConceptsTarget vessel failurePS stentPalmaz-SchatzMajor adverse cardiac eventsNative vessel lesionsAdverse cardiac eventsPrimary end pointNative coronary arteriesSuccessful stent deliveryPalmaz-Schatz stentsAngiographic outcomesCardiac eventsAngiographic restudyAcute resultsDiameter stenosisVessel lesionsCoronary arteryVessel failureClinical equivalenceStent deliveryNonsignificant trendPatientsExcellent deliverabilityEnd pointStents
2000
Randomized Comparison of GR-II Stent and Palmaz-Schatz Stent for Elective Treatment of Coronary Stenoses
Lansky A, Roubin G, O’Shaughnessy C, Moore P, Dean L, Raizner A, Safian R, Zidar J, Kerr J, Popma J, Mehran R, Kuntz R, Leon M. Randomized Comparison of GR-II Stent and Palmaz-Schatz Stent for Elective Treatment of Coronary Stenoses. Circulation 2000, 102: 1364-1368. PMID: 10993853, DOI: 10.1161/01.cir.102.12.1364.Peer-Reviewed Original ResearchConceptsCoronary stenosisPalmaz-SchatzElective treatmentDe novo native coronary stenosisStent minimal lumen diameterMultivariate logistic regression analysisPrimary end pointTarget lesion revascularizationFree survival rateStent thrombosis ratesLong-term followNative coronary stenosisMinimal lumen diameterLogistic regression analysisPalmaz-Schatz stentsBalloon angioplasty proceduresRestenosis frequencyAngiographic restenosisLesion revascularizationProspective multicenterTLR rateFree survivalAcute treatmentConsecutive patientsDiabetes mellitus
1998
Paradoxic Decreases in Atherosclerotic Plaque Mass in Insulin-Treated Diabetic Patients
Kornowski R, Mintz G, Lansky A, Hong M, Kent K, Pichard A, Satler L, Popma J, Bucher T, Leon M. Paradoxic Decreases in Atherosclerotic Plaque Mass in Insulin-Treated Diabetic Patients. The American Journal Of Cardiology 1998, 81: 1298-1304. PMID: 9631966, DOI: 10.1016/s0002-9149(98)00157-x.Peer-Reviewed Original ResearchConceptsArterial areaPlaque accumulationLumen compromiseDe novo native coronary stenosisInsulin-treated patientsInsulin-treated diabeticsNative coronary stenosisMultivariate linear regression analysisAtherosclerotic lesion formationBody surface areaParadoxic decreaseInsulin useDiabetes mellitusDiabetic patientsIndependent predictorsRemodeling indexAnginal syndromePlaque burdenCoronary stenosisArterial shrinkageInsulin treatmentPlaque massIntravascular ultrasoundLinear regression analysisReference segments